Excitatory neurotransmitter glutamate triggers an increase in intracellular calcium concentration ([Ca 2ϩ ] i ) both through extracellular Ca 2ϩ influx and intracellular Ca 2ϩ mobilization (1) (2) (3) . Glutamate interacts with two distinct types of receptors, namely, ionotropic and metabotropic glutamate receptors (4) . The ␣-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid-type ionotropic receptors depolarizes membrane potentials and induces Ca 2ϩ influx through voltage-sensitive Ca 2ϩ channels (VSCCs) 1 (3, 5) . Glutamate also activates N-methyl-D-aspartic acid-type ionotropic receptors and enhances Ca 2ϩ influx through these calcium-permeable receptors (1) (2) (3) (4) . Metabotropic glutamate receptors (mGluRs) are the family of G protein-coupled receptors (4, 6) . Eight different subtypes of mGluRs exist, and these are classified into three groups (4, 6) . Group 1 mGluRs (mGluR1 and mGluR5) stimulate phosphatidylinositol hydrolysis to generate the second messengers diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ) (7, 8) . IP 3 mobilizes intracellular Ca 2ϩ through interaction with IP 3 receptors (9) . The glutamate-mediated increase in [Ca 2ϩ ] i plays an important role in regulating a variety of neuronal processes, including neural development, synaptic plasticity, and neuronal cell degeneration (10 -12) .
Several Ca 2ϩ signaling molecules are located in close proximity and linked through protein-protein interaction. This assembly of Ca 2ϩ signaling molecules contributes to efficient activation of specific Ca 2ϩ signaling cascades and cross-talk between different Ca 2ϩ signaling pathways (3, (12) (13) (14) . Ca v 2.1 is a pore forming membrane protein of VSCC and mediates P-type and P/Q-type Ca 2ϩ currents with auxiliary ␣/␦ and ␤ subunits (15) (16) (17) (18) . Both Ca v 2.1 and mGluR1a, a large splice variant of mGluR1, are highly expressed in the Purkinje neurons (PNs) in the cerebellum (19 -24) . Gene targeting showed that both Ca v 2.1 and mGluR1 are important for the network formation and function of the cerebellum (18, 25, 26) . Furthermore, coincident stimulation of mGluR1 and VSCC has been shown to potentiate [Ca 2ϩ ] i increase in PNs (27) . The coincident rise in [Ca 2ϩ ] i is important for integrating synaptic inputs to PNs (2, 28, 29) . In contrast, the stimulation of group 1 mGluRs has been shown to inhibit P/Q-type Ca 2ϩ channels in cortical and globus pallidus neurons (30, 31) . However, neither temporally regulated mechanisms of mGluR1-mediated P/Qtype Ca 2ϩ channel modulation nor the physical interaction between mGluR1 and P/Q-type Ca 2ϩ channels have been addressed yet. In this investigation, we report that mGluR1a and Ca v 2.1 form a protein complex through direct interaction between these two proteins. We also show that the heteromeric assembly of mGluR1a and Ca v 2.1 plays an important role in temporally regulated [Ca 2ϩ ] i increase in both cultured PNs and heterologously expressing cells.
EXPERIMENTAL PROCEDURES
Immunohistochemistry-All procedures were performed according to guidelines of Kyoto University Faculty of Medicine. Immunohistochemistry of mouse cerebellar sections (40 m) was performed with use of rabbit anti-mGluR1a antibody (32) and rabbit anti-Ca v 2.1 antibody (Alomone and Sigma) as described previously (33, 34) . PNs were cultured as described previously (35) . For immunostaining of cultured PNs, the cells were first reacted with the human antibody against the extracellular region of mGluR1 (36) and fixed with 1% paraformaldehyde for 3 min. The fixed cells were permeabilized, blocked, and reacted with rabbit anti-Ca v 2.1 antibody. Immunoreactive signals were visualized with Alexa568-conjugated anti-rabbit IgG (Molecular Probes) and fluorescein isothiocyanate-conjugated anti-human IgG (Caltag). For double-immunofluorescence staining, cerebella were cut into sections of 30-m thickness before fixation. The sections were fixed with 4% paraformaldehyde and 1% picric acid in 0.1 M phosphate buffer (pH 7.4) for 10 min and reacted with human anti-mGluR1 antibody (36) and rabbit anti-Ca v 2.1 antibody. Immunoreactive signals were visualized with Alexa488-conjugated anti-human IgG and Alexa594-conjugated anti-rabbit IgG antibodies (Molecular Probes).
Immunoprecipitation, Immunoblotting, and Pull-down Assay-For COS-7 cell expression, Myc/His tag was introduced into the carboxylterminal end of rabbit Ca v 2.1 (BI-2 clone, GenBank TM CAA40715) (16) by PCR. Myc/His-tagged Ca v 2.1 (Ca v 2.1-Myc-His) was inserted into the pcDNA3.1 mammalian expression vector (Invitrogen). The mammalian expression vector for rat mGluR1a was described previously (37) . Expressed mGluR1a and Ca v 2.1-Myc-His were immunoprecipitated with rabbit anti-mGluR1a (32) and anti-Myc (Santa Cruz Biotechnology) antibodies, respectively. The immunoprecipitates were immunoblotted with mouse anti-His (Qiagen) and anti-mGluR1a (BD Transduction) antibodies. For in vitro pull-down assays, the whole carboxyl-terminal region of rat mGluR1a (amino acid residues 841-1199, GenBank TM CAA40799) was fused to the carboxyl-terminal end of His/FLAG-tagged enhanced green fluorescent protein (EGFP, Clontech) (HFG-1CT), and HFG-1CT was inserted into pFASTBAC (Invitrogen). Other intracellular regions of rat mGluR1a and rabbit Ca v 2.1 were constructed by PCR and inserted in-frame into pET-32a (Novagen) and pGEX-4T-1 (Amersham Biosciences), respectively; the regions used for rat mGluR1a were as follows: 1CT-1, residues 841-932; 1CT-2, 933-1013; 1CT-3, 1035-1073; and 1CT-4, 1080 -1199; the regions used for rabbit Ca v 2.1 were as follows: CavNT, residues 1-98; CavI-II, 361-487; CavII-III-1, 715-1036; CavII-III-2, 1011-1253; CavIII-IV, 1521-1575; CavCT, 1821-2424; CavCTa, 1975-2424; CavCTb, 1821-2024; and CavCTc, 1821-2164. Proper in-frame insertions and the absence of any sequence errors of all PCR products were confirmed by DNA sequencing. The HFG-1CT protein was produced with use of the Bac-to-Bac baculovirus expression system (Invitrogen) and HighFive cells and purified with nickel-nitrilotriacetic acid-agarose (Qiagen). GST fusion proteins were expressed in Escherichia coli and purified with glutathione-Sepharose 4B beads. The concentrations of purified proteins were determined by DC protein assay kit (Bio-Rad). His-tagged thioredoxin fusion proteins were expressed in E. coli and purified with nickel-nitrilotriacetic acidagarose. The purified proteins we used were more than 90% of purity as analyzed by Coomassie Brilliant Blue R250 staining after PAGE. One microgram of the purified proteins was used for both protein immobilization and protein binding in pull-down assays. The procedures for transfection, protein purification, immunoprecipitation, immunoblotting, and GST pull-down assays were described previously (38) .
Calcium Imaging and Electrophysiological Recording of HEK293 Cells-HEK293 cells expressing the BI-2 form of Ca v 2.1 together with the auxiliary ␣2/␦ and ␤1 subunits (HEK-Cav) were established as described previously (39) , except that the pKCRH2-neo vector (40) used for expression of BI cDNA. The mammalian expression vector containing mGluR1a was cotransfected with the EGFP-N1 (Clontech) marker-containing vector at a ratio of 10:1 using SuperFect reagent (Qiagen). EGFP-expressing cells were identified with excitation at 480 nm and emission at 510 nm. Measurement of Fura-2 fluorescence was performed as described previously (41, 42) . Intensities of fluorescent light emission at 510 nm, using excitation at 340 and 380 nm, were converted to Ca 2ϩ concentrations as described previously (42) . Wholecell recording of Ba 2ϩ currents was conducted as described previously (39) . An external solution contained (mM) 3 BaCl 2 , 155 tetraethylammonium chloride, 10 HEPES, and 10 creatine, adjusted to pH 7.2. A pipette solution contained (mM) 85 cesium aspartate, 40 CsCl, 4 MgCl 2 , 5 EGTA, 2 ATP-Mg, 5 HEPES, and 10 creatine phosphate, adjusted to pH 7.2. In some experiments, cells were preincubated with staurosporin or U73122 for ϳ5 min by adding 500 nM staurosporin (Sigma) and 1 M U73122 (Calbiochem) in the pipette solution or pretreated with 300 ng/ml PTX (Seikagaku) for 24 h. The current-voltage relationship was obtained by holding the membrane potential at Ϫ80 mV and then delivering a depolarizing pulse for 30 ms in a stepwise manner with 10-mV increments from Ϫ50 to 60 mV.
Calcium Imaging of Cultured PNs-Primary culture and calcium imaging of PNs were performed as described previously (35) . Briefly, PNs were loaded with Fura-2AM (10 M, Molecular Probes) for 30 min at 37°C. Recording was made with excitation at 340 and 380 nm for 250 ms and emission at 510 nm. Cells were first stimulated with 25 mM KCl in the culture medium containing 1 M tetrodotoxin (Sigma), 10 M 6-cyano-7-nitroquinoxaline-2,3-dione (Tocris), and 20 M bicuculline (Sigma) (Medium A). The medium was replaced with the normal culture medium and incubated in the presence and absence of 50 M 3,5-dihydroxyphenylglycine (DHPG) (Tocris), 50 M DHPG plus 10 M 7-hydroxyiminocyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) (Tocris) and 100 nM -agatoxin IVA (Peptide Institute). The incubation was carried out at 37°C for 10 min in a CO 2 incubator with 5% CO 2 /95% air. PNs were then stimulated with 25 mM KCl in Medium A with and without the above agonists or antagonists at 24°C.
RESULTS

Colocalization of mGluR1a and Ca v 2.1 in Cerebellar PNs-It
has been shown that mGluR1a is abundantly expressed in PNs (24, 43) , whereas Ca v 2.1 is distributed at both granule cells and PNs (19, 21, 22) . We examined codistribution of mGluR1a and Ca v 2.1 by immunostaining of mouse cerebellar sections with anti-mGluR1a and anti-Ca v 2.1 antibodies (Fig. 1, A and B) . Strong immunoreactive signals of mGluR1a and Ca v 2.1 were observed throughout the molecular layer of the cerebellum (Fig.  1, A and B) . Neither mGluR1a nor Ca v 2.1 immunoreactivity was seen in cerebellar sections of mGluR1 knockout mice (32, 36) and Ca v 2.1 knockout mice, 2 respectively, with the antibodies we used. Double immunostaining of cerebellar sections was carried out with anti-mGluR1 and anti-Ca v 2.1 antibodies. This analysis showed that intense immunoreactive signals of the two proteins overlapped throughout the molecular layer but both signals were weak at the Purkinje cell layer (Fig. 1, C-E) . We further characterized mGluR1 and Ca v 2.1 immunoreactivities in cultured PNs, which extended long dendritic branches during continuing culture. Both immunoreactivities showed punctuate labeling patterns and were colocalized at the dendrites of cultured PNs (Fig.  1F) . Immunoreactive signals of Ca v 2.1 were also seen on soma of cultured PNs, but mGluR1a was poorly immunostained on this region (Fig. 1G) .1 and rat mGluR1a tested for GST pull-down assays are shown in A and B, respectively. C, GST and GST fusion proteins containing the intracellular fragments of Ca v 2.1 were immobilized on glutathione-Sepharose 4B beads and incubated with the whole intracellular carboxyl-terminal domain of mGluR1a fused to His/FLAG-tagged EGFP (HFG-1CT); 1 g each of purified GST, GST fusion proteins, and HFG-1CT was used for all experiments. Bound proteins were immunoblotted with anti-His antibody. D, purified GST and GST fusion proteins containing four different carboxyl-terminal regions of Ca v 2.1 (1 g each) were analyzed as in C. E, purified GST and GST fusion proteins containing CavCT (1 g each) were immobilized on glutathione-Sepharose 4B beads and incubated with His-tagged thioredoxin fused to four different carboxyl-terminal regions of mGluR1a (1 g each). Bound proteins were immunoblotted with anti-His antibody. Inputs show equivalent amounts of the fusion proteins used for GST pull-down assays in C-E. possible protein assembly of mGluR1a and Ca v 2.1 in vivo by immunoprecipitation of solubilized rat brain membrane fractions. Solubilized membrane fractions were immunoprecipitated with anti-Ca v 2.1 and anti-mGluR1a antibodies, and the immunoprecipitates were immunoblotted with anti-mGluR1a and anti-Ca v 2.1 antibodies, respectively. The result showed that anti-Ca v 2.1 and anti-mGluR1a antibodies mutually coimmunoprecipitated mGluR1a and Ca v 2.1, respectively (Fig. 2, A  and B) . In control, neither of them was detected in immunoprecipitates with nonimmunized control IgG (Fig. 2, A and B) .
The complex formation of mGluR1a and Ca v 2.1 was further examined by cotransfection of mGluR1a and Myc/His-tagged Ca v 2.1 (Ca v 2.1-Myc-His) into COS-7 cells. COS-7 cell lysates were immunoprecipitated with anti-Myc and anti-mGluR1a antibodies, and the immunoprecipitates were immunoblotted with anti-mGluR1a and anti-His antibodies, respectively. AntiMyc and anti-mGluR1a antibodies coimmunoprecipitated mGluR1a and Ca v 2.1-Myc-His in lysates of transiently cotransfected COS-7 cells, respectively (Fig. 2, C and D, lane 6) . This coimmunoprecipitation was not seen in cells transfected with either mGluR1a or Ca v 2.1-Myc-His alone (Fig. 2, C and D,  lanes 5 and 7) nor from cotransfected cell lysates precipitated with nonimmunized control IgG (Fig. 2, C and D, lane 8) . These results indicate that mGluR1a and Ca v 2.1 form a protein complex in both rat brain and heterologously expressing cells.
Direct Interaction between mGluR1a and Ca v 2.1-To examine the direct protein-protein interaction between mGluR1a and Ca v 2.1, we dissected the intracellular domains of Ca v 2.1 and then tested their ability to bind to the whole carboxylterminal domain of mGluR1a by in vitro pull-down assay. The amino-terminal domain, the intracellular loops, and the carboxyl-terminal domain of Ca v 2.1 were fused to GST (Fig. 3A) , expressed in E. coli, and purified. The whole intracellular carboxyl-terminal domain of mGluR1a was fused to His/FLAGtagged EGFP (HFG-1CT), expressed in insect cells, and purified (Fig. 3B) . The various GST fusion proteins were immobilized on glutathione-Sepharose 4B beads and incubated with HFG-1CT. Bound proteins were eluted and immunoblotted with anti-His antibody (Fig. 3, A and C) . This analysis showed that the carboxyl-terminal domain of mGluR1a not only bound strongly to the carboxyl-terminal portion of Ca v 2.1 (amino acid residues 1821-2424; GST-CavCT) but also weakly to the intracellular loop II-III (residues 715-1036; GST-CavII-III-1) of Ca v 2.1 (Fig. 3C) . We further defined the interaction site of the intracellular carboxyl-terminal region of Ca v 2.1 (Fig.  3, A and D) . The GST fusion protein containing residues of 1975-2424 of Ca v 2.1 (GST-CTa) bound to HFG-1CT (Fig. 3D) . Two amino-terminal portions covering residues 1821-2024 and Ba 2ϩ currents at each depolarization potential were averaged; n ϭ 19 for mGluR1a and n ϭ 18 for control. Circles and bars indicate mean Ϯ S.E. D, Ba 2ϩ currents elicited by a depolarizing pulse of 10 mV from the holding potential at Ϫ80 mV were measured by whole-cell recordings of control HEK-Cav cells (n ϭ 5) and mGluR1a-expressing HEK-Cav cells with (n ϭ 5) and without (n ϭ 17) pretreatment of PTX (300 ng/ml) for 24 h. Columns and bars indicate mean Ϯ S.E.; *, p Ͻ 0.05; n.s., not significant. (Fig. 3D) , suggesting that the remaining carboxyl-terminal domain of Ca v 2.1 is a likely candidate for interaction with mGluR1a. To confirm this observation, we attempted to express GSTs fused to the carboxyl-terminal portions of residues 2025-2424 or 2116 -2424 of Ca v 2.1 in E. coli. However, these fusion proteins could not be detected in E. coli lysates, probably due to their rapid degradation. Although we have not proceeded further with this analysis, it is clear from the data so far attained that the intracellular carboxyl-terminal region of Ca v 2.1 directly interacts with the intracellular region of mGluR1a.
1821-2164 (GST-CTb and GST-CTc) failed to bind to HFG-1CT
The binding site of mGluR1a was also examined by dividing its carboxyl-terminal portion into four regions, each fused to His-tagged thioredoxin (HT-1CT-1 to HT-1CT-4) (Fig. 3B) . The four HT-1CT proteins were expressed in E. coli, purified, and incubated with glutathione-Sepharose 4B beads attached with GST-CavCT. Bound proteins were immunoblotted with antiHis antibody (Fig. 3E) . This analysis showed that the carboxylterminal region close to the seventh transmembrane domain of mGluR1a (residues 841-932) is responsible for a strong interaction with the carboxyl-terminal domain of Ca v 2.1 (Fig. 3E) . The interaction between loop II-III of Ca v 2.1 and the carboxylterminal domain of mGluR1a was not of sufficient strength (Fig. 3C) (Fig. 4A) . This inhibition was indeed ligandindependent, because an mGluR1 antagonist, CPCCOEt (10 M), had no effect on the mGluR1a-mediated inhibition of [Ca 2ϩ ] i increase (Fig. 4B) . The inhibitory effect of mGluR1a was further confirmed by whole-cell recording of Ca v 2.1-mediated Ba 2ϩ currents in HEK-Cav cells. When membrane potentials were depolarized from a holding potential of Ϫ80 mV to positive potentials, HEK-Cav cells gave rise to inward Ba 2ϩ currents in the Ba 2ϩ -containing external solution (Fig. 4C, left  panel) . The current-voltage relationship of Ba 2ϩ currents showed a bell-shape characteristic of P/Q-type channels (39) (Fig. 4C, right panel) . Comparison of mGluR1a-expressing and control HEK-Cav cells showed that Ba 2ϩ currents were significantly inhibited by coexpression of mGluR1a at all ranges of depolarization potentials (n ϭ 19 for mGluR1a and n ϭ 18 for control; p Ͻ 0.001, repeated measures analysis of variance) (Fig. 4C) . When mGluR1a-expressing HEK-Cav cells were pretreated with the G i /G o inhibitor PTX (300 ng/ml), the protein kinase C inhibitor staurosporin (500 nM), or the phospholipase C inhibitor U73122 (1 M), they failed to relieve the mGluR1a-mediated inhibition of Ba 2ϩ currents (Fig. 4D and data not shown). This finding indicates that the ligand-independent inhibition of Ca v 2.1 channels is derived from expression of mGluR1a per se rather than involvement of G proteins or their downstream effectors.
Temporally Regulated Modulation of Ca v 2.1 Channels by mGluR1a
Activation-We next addressed whether ligand activation of mGluR1a affects depolarization-induced [Ca 2ϩ ] i increase by calcium imaging. When mGluR1a was activated by application of group 1 mGluR-selective agonist, DHPG, 5 min prior to depolarization, the activation of mGluR1a caused strong inhibition of KCl-induced [Ca 2ϩ ] i increase (Fig. 5A ). mGluR1a thus inhibited the Ca v 2.1-mediated [Ca 2ϩ ] i increase in both a ligand-independent and a ligand-dependent manner. The ligand-dependent inhibition was further confirmed by whole-cell recording of Ba 2ϩ currents. Preincubation of these cells with glutamate (100 M) significantly inhibited depolarization-inducedBa 2ϩ currents (Fig.5B) .Furthermore,thisliganddependent inhibition was at least partially relieved by pretreatment with PTX (300 ng/ml) (Fig. 5B) . However, neither staurosporin (500 nM) nor U73122 (1 M) showed any suppressive effect on ligand-dependent inhibition of Ba 2ϩ currents (Fig. 5B) : percentages of inhibition of Ba 2ϩ currents, relative to Ba 2ϩ currents measured in the absence of glutamate, were 's t test) . B, mGluR1a-expressing HEK-Cav cells were preincubated with or without 100 M glutamate for ϳ30 s in the presence and absence of PTX (300 ng/ml), staurosporin (500 nM), and U73122 (1 M). Ba 2ϩ currents were evoked by a depolarizing pulse of 10 mV (as shown by an arrow) for 50 ms from the holding potential at Ϫ80 mV and measured by whole-cell recording.
26.9 Ϯ 2.8% for glutamate alone (n ϭ 18), 12.1 Ϯ 1.5% for glutamate plus PTX (n ϭ 5; p Ͻ 0.05; Student's t test), 32.1 Ϯ 10.0% for glutamate plus staurosporin (n ϭ 5), and 36.0 Ϯ 6.9% for glutamate plus U73122 (n ϭ 2). The membrane-delimited mGluR1a-G i /G o signaling is thus most likely implicated in the ligand-dependent, mGluR1a-mediated inhibition of Ca v 2.1 channels.
Application of DHPG alone increased [Ca 2ϩ ] i by mobilizing Ca 2ϩ from intracellular Ca 2ϩ stores (Fig. 5A) (7) . When mGluR1a and Ca v 2.1 channels were simultaneously activated by DHPG and high KCl, [Ca 2ϩ ] i was markedly increased as compared with a [Ca 2ϩ ] i increase elicited by either high KCl or DHPG alone (Fig. 5A ). This finding indicates that mGluR1a in association with Ca v 2.1 channels plays an important role in a temporally regulated [Ca 2ϩ ] i increase. (Fig. 6, A and B) . The [Ca 2ϩ ] i increases were blocked at both dendrites and soma by the P-type channel blocker -agatoxin IVA (n ϭ 3) (Fig. 6C ). This finding was consistent with previous pharmacological and electrophysiological studies indicating the predominant role of P-type Ca 2ϩ channels in Ca 2ϩ permeation of PNs (5, 44) . The mGluR1-mediated modulation of P-type channels was then examined by addition of DHPG (50 M) before and at the time when P-type channels were activated by high KCl. Extents of P-type channel activation were unchanged when PNs were depolarized twice with a 10-min interval by high KCl (n ϭ 5) (Fig. 6C) . When DHPG was added during a 10-min interval, it significantly inhibited the P-type channel-mediated [Ca 2ϩ ] i increase at dendrites of PNs (Fig. 6 ). Because mGluR5 was undetectable in PNs with both in situ hybridization and immunohistochemistry (8, 45) , the effect of DHPG was attributable to the inhibitory function of mGluR1 on P-type Ca 2ϩ channels. Furthermore, the inhibition by DHPG was blocked by concomitant incubation of an mGluR1 antagonist CPCCOEt (10 M) (data not shown). mGluR1 is thus responsible for inhibition of the P-type channel activity.
Modulation of P-type Channel Activity by mGluR1 Agonists in Cultured PNs
The dendrites of PNs (Fig. 6C) . Furthermore, reflecting the predominant localization of mGluR1 at dendrites over soma of PNs (Fig. 1, F and G) , both stimulatory and inhibitory effects of mGluR1 on [Ca 2ϩ ] i increase were confined to dendrites of PNs (Fig. 6 ). This finding indicates that the functional coupling of mGluR1 and Ca v 2.1 plays an important role in spatiotemporal modulation of P-type channels at PNs.
DISCUSSION
This investigation has demonstrated that mGluR1a and Ca v 2.1 are colocalized in dendrites of PNs and form the heteromeric assembly in both the rat brain and heterologously expressing COS-7 cells. This assembly occurs through the direct interaction between the carboxyl-terminal region of Ca v 2.1 and the cytoplasmic region close to the seventh transmembrane region of mGluR1a. The binding region of mGluR1a is relatively hydrophilic (23) and possesses Ca 2ϩ /calmodulin binding motifs (46) . This region has been shown not only to interact with Ca 2ϩ /calmodulin and E3 ubiquitin ligase Siah (46) but also to be essential for coupling to the G protein G␣ q (47) . The discrete binding region of Ca v 2.1 remains to be determined, but truncation analysis suggests that the distal portion of the intracellular carboxyl-terminal region of Ca v 2.1 is a likely candidate for interaction with mGluR1a. Sequence data analysis of this region has shown the presence of several sequence motifs, including proline-rich (residues 2308 -2394), arginine-rich (residues 2202-2404), and histidine-rich sequences (residues 2216 -2227), which have been implicated in protein-protein interaction. Recently, evidence is accumulated indicating that several transmembrane receptors and ion channels form heteromers through direct protein-protein interaction. The ␥-aminobutyric acid, type A receptor channels selectively complex with dopamine D5 receptor through the direct interaction between the D5 receptor carboxyl-terminal domain and the intracellular loop of the ␥-aminobutyric acid, type A, ␥2 receptor subunit (48) . This interaction confers mutual inhibition in a ligand-dependent manner (48) . The sigma receptor also binds to the Kv1.4 and Kv1.5 voltage-gated K ϩ channels and inhibits the K ϩ channel activity in different ways in the presence and absence of sigma receptor ligands (49) . The ␤2 adrenergic receptor not only associates with L-type Ca 2ϩ channels but also forms a multimolecular signaling complex, thus affording highly localized signal transduction from the receptor to the Ca 2ϩ channels (50) . mGluR1 binds to key scaffold proteins, homers and tamalin, which form protein complexes with multiple synaptic scaffold proteins and intracellular signaling molecules (38, (51) (52) (53) (54) . The assembly of mGluR1, Ca v 2.1, and signaling molecules may thus provide mechanisms that ensure specific and efficient signaling in mGluR1-mediated glutamatergic transmission.
The inhibition of P/Q-type Ca 2ϩ channels by group 1 mGluRs has been reported in several neuronal cells as well as heterologously expressing cells (30, 31, 55) . This investigation has indicated that mGluR1a inhibits Ca v 2.1 Ca 2ϩ channels in both ligand-dependent and ligand-independent manners, which are mediated by the mechanisms of the membrane-delimited G i /G o coupling and the physical coupling between the two proteins, respectively. In cultured PNs, Ca v 2.1 channels are distributed at both soma and dendrites, but mGluR1 is mainly localized at dendrites. Reflecting the specialized localization of mGluR1, the pre-activation of mGluR1 preferentially inhibits P-type channels at the dendrites of cultured PNs. This dendritic inhibition of P/Q-type Ca 2ϩ channels may commonly occur in other neurons, because the similar inhibition of P/Q-type Ca 2ϩ channels by mGluRs has been reported in isolated hippocampal dendritic segments (56 (27) (28) (29) . It is therefore tempting to speculate that the temporally regulated modulation of Ca v 2.1 Ca 2ϩ channels by mGluR1a contributes to integration of synaptic inputs onto PNs.
